Major resource companies and banks are sector picks for Glenn Rosewall, CEO and managing director of BBY, speaking to Mike Elliott, global m...
Targacept just reported a better than expected quarter, with Mad Money host Jim Cramer.
Despite the extension of the home buyer tax credit, real estate executives expect more pain ahead, with CNBC's Diana Olick; Margaret Kelly, ...
It's a new house of cards for a former Bear Stearns executive, with Steve Begleiter and CNBC's Darren Rovell.
Insight on the market action, with Matthew Cheslock, Cohen Capital Group; George Gero, RBC Capital Markets; and CNBC's Sue Herera.
Wayne Pisano, CEO of Sanofi-Pasteur, discusses the making of the flu vaccine with CNBC's Mike Huckman.
Flu vaccines were once a business that many drug companies avoided, but that segment of the pharma industry is now firmly in the spotlight. ...
While the jobs picture is still dismal, there ae some companies in hiring mode. NuStar Energy, a pipeline and refinery operator based in San...
Flu vaccines were once a business that many drug companies avoided, but that segment of the pharma industry is now firmly in the spotlight. ...
UK Business Secretary Lord Mandelson and Olympics Minister Tessa Jowell joined London 2012 organizers to launch a £700 million tender for go...
British Airways swung to a worse-than-expected loss in the third quarter Friday, but said it sees traffic volumes stabilizing. John Strickla...
Debating whether insider trading should be legalized, with Sam Antar, former Crazy Eddie Inc. CFO and Don Boudreaux, George Mason University...
Discussing cancer research companies that could be the best opportunities for investors, with Paul Berns, Allos Therapeutics president/CEO.
A check on what's next with the markets, with Louise Yamada, Louise Yamada Technical Research Advisors.
A look at the trading day, with Stuart Freeman, Wells Fargo Advisors and CNBC's Tyler Mathisen, Bill Griffeth, Ron Insana & Maria Bartiromo.
Some U.S. companies are clamoring to sell to Cuba, reports CNBC's Tyler Mathisen and James Jakoby.
The Lazard board is grappling over who will succeed Wasserstein, with CNBC's Charlie Gasparino.
Tyler Vernon, of Biltmore Capital, and Steve Hochberg, of Elliott Wave International, share their investment strategies.
News |
COMPANY : Bear Stearns
Wednesday, 4 Nov 2009
Wednesday, 28 Oct 2009
Monday, 26 Oct 2009
Source: The New York Times
Wednesday, 30 Sep 2009
About CNBC | Site Map | Privacy Policy | Terms of Service | Video Reprints | Advertise | Help | Contact
Partners: AOL Money | BloggingStocks.com
Partners: AOL Money | BloggingStocks.com
Data is a real-time snapshot *Data is delayed at least 15 minutesGlobal Business and Financial News, Stock Quotes, and Market Data and Analysis
© 2009 CNBC, Inc. All Rights Reserved.
A Division of NBC Universal
